Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
(Riboflavin + sodium iodide) by Epion Therapeutics for Keratoconus: Likelihood of Approval
(Riboflavin + sodium iodide) is under clinical development by Epion Therapeutics and currently in Phase III for Keratoconus. According to...